DAILY EQUTY REPORT BY EPIC RESEARCH-20 NOVEMBER 2012
Upcoming SlideShare
Loading in...5
×
 

DAILY EQUTY REPORT BY EPIC RESEARCH-20 NOVEMBER 2012

on

  • 222 views

 

Statistics

Views

Total Views
222
Views on SlideShare
222
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

DAILY EQUTY REPORT BY EPIC RESEARCH-20 NOVEMBER 2012 DAILY EQUTY REPORT BY EPIC RESEARCH-20 NOVEMBER 2012 Document Transcript

  • HEADLINES  Indian Market Indian equity markets down by 0.05%. Nifty down by 2.65 pts and settle at 5571.40 Sensex up by 29.63 pts at 18339.00. Bank Nifty down by 28.55 pts at 11306.95 DAILY EQUITY  Global Market NEWSLETTER European markets were up with FTSE TH up by 57.99 pts at 5663.58,CAC up by 20 NOVEMBER 2012 45.05 pts at 3371.56 and DAX up by 92.48 pts at 7043.01 Dow future up by 50.00 pts at 12620.00  HEADLINES• NALCO halts operations at bauxite mine: Executive• Coal scam loss figure will also turn out to be mythical: FM• 2G case: RBI Governor D Subbarao deposes in court• Bharti Airtel gain on tariff hike hopes WWW.EPICRESEARCH.CO 09752199966
  •  MARKET ANALYSIS:  Key benchmark indices edged higher in choppy trade as firm global stocks boosted sentiment. The market sentiment was also boosted by provisional data showing that foreign institutional investors (FIIs) remained net buyers of Indian stocks on Friday, 16 November 2012.  The BSE Sensex was up 50.19 points or 0.27% to 18,359.26.  The S&P CNX Nifty was up 2.25 points or 0.04% to 5576.30, as per provisional figures.  From the 30-share Sensex pack, 18 stocks fell while the rest of them rose.  Car major Maruti Suzuki India jumped 3.83% to Rs 1,494. The stock hit 52-week high of Rs 1,505.80 in intraday trade today, 19 November 2012. The company early this month said its total sales jumped 85.5% to 1.03 lakh units in October 2012 over October 2011. Capital goods stocks extended recent losses as data last week showed that capital goods production slumped 12.2% in September 2012 from a year earlier. L&T fell 1.08%. The company announced after market hours Friday, 16 November 2012, it has agreed to sell its medical equipment business based at Mysore to Skanray Healthcare. L&T did not unveil the amount of sale consideration. STOCKS TO WATCH  FII’s and DII’s  INFOSYSCATEGORY DATE BUY SELL NET  AMBUJA FII 19-Nov-12 1738.25 1739.77 -1.52  ARVIND  HDIL DII 19-Nov-12 766.47 1269.07 -502.6 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  SUZLONPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 5699 5656 5613 5592 5570 5549 5527 5484 5441  PUNJLYOD  WELCORP WWW.EPICRESEARCH.CO 09752199966
  • .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks SidewaysSCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips (000) CLOSE CHAN CHANG GE E  Support:5530 Maruti 1494.25 1688.46 1438.10 56.15 3.90  Resistance: 5610 Suzuki Bharti BANK NIFTY 309.50 8406.64 301.40 8.10 2.69 Airtel  Bank Nifty looks Sideways ITC 281.70 5485.11 274.65 7.05 2.57  Strategy: Buy on dips Bajaj Auto 1850.55 261.77 1813.55 37.00 2.04  Support:11230 M&M 908.80 1298.56 894.45 14.35 1.60  Resistance:11380  PREVIOUS PERFORMANCE DAILY NIFTY LOOSERS TYPE SCRIP B/S RESULTSCRIPS RATE VOL. PR. NET % (000) CLOSE CHAN CHA AUROBINDO TGT CASH B PHARMA ACHEIVED GE NGE CENTURY CASH B SL TRIGGERED TEXTILE IDFC 154.40 7102.62 159.35 -4.95 -3.11 JINDAL TGT FUTURE B STEEL ACHEIVED Lupin 561.90 712.50 576.60 -14.70 -2.55 TGT Tata FUTURE GODREJ S 96.85 2602.77 99.10 -2.25 -2.27 ACHEIVED Power JP 89.15 17975.21 90.95 -1.80 -1.98Associate TCS 1262.35 838.14 1286.80 -24.45 -1.90 09752199966
  • MARKET CALLS CASH ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS EXIDE BUY 139.50 141.00 143.00 137.95 DELTA CORP SELL 74.30 73.50 72.50 75.10 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. AMBUJA SELL 199.00 198.00 196.50 200.05 HDIL BUY 104.70 105.20 106.00 104.20 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forw ard or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.